Consensus recommendations on the use of botulinum toxin type A in facial aesthetics

Plastic and Reconstructive Surgery

Volumn 114, Issue 6 SUPPL., 2004, Pages

  Carruthers, Jean ^b   Fagien, Steven ^b   Matarasso, Seth L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BOTULINUM TOXIN A;

CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG USE; DYSPHAGIA; ESTHETICS; EVALUATION; EYEBROW; EYEBROW PTOSIS; FACE MUSCLE; GENDER; HUMAN; MEDICAL EXPERT; MUSCLE DISEASE; ORBICULARIS OCULI MUSCLE; ORBICULARIS ORIS MUSCLE; PATIENT COUNSELING; PATIENT SELECTION; PLATYSMA MUSCLE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPRIOCEPTION; PTOSIS; PUBLICATION; REVIEW; SAFETY; SENSORY DYSFUNCTION; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; WRINKLE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG EFFECT; FACE; FEMALE; FOREHEAD; INSTRUMENTATION; MALE; METHODOLOGY; MOUTH; NOSE; PARALYSIS; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

BOTULINUM TOXIN TYPE A; ESTHETICS; FACE; FACIAL MUSCLES; FEMALE; FOREHEAD; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MOUTH; NOSE; PARALYSIS; SEX FACTORS;

EID: 7044227820     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000144795.76040.D3     Document Type: Review

References (62)

1. Allergan, Inc. Botox Cosmetic (botulinum toxin type A) purified neurotoxin complex (Package Insert). Irvine, Calif.: Allergan, Inc.
2. Klein, A. W. Dilution and storage of botulinum toxin. Dermatol. Surg. 24: 1179, 1998.
3. Carruthers, A., Carruthers, J., Cohen, J., and Alain, J. Dose dilution and duration of effect of botulinum toxin type A (BTX-A) for the treatment of glabellar rhytids. Poster presented at the 2002 Winter Meeting of the American Academy of Dermatology, New Orleans, La., February 22-27, 2002.
4. Klein, A. W. Complications and adverse reactions with the use of botulinum toxin. Dis. Mon. 48: 336, 2002.
5. Hexsel, D. M., de Almeida, A. T., Rutowitsch, M., et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol. Surg. 29: 523, 2003.
6. Garcia, A., and Fulton, J. E., Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin: A dose-response study. Dermatol. Surg. 22: 39, 1996.
7. Alam, M., Dover, J. S., and Arndt, K. A. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: A double-blind, randomized controlled trial. Arch. Dermatol. 138: 510, 2002.
8. Trindade de Almeida, A. R., Kadunc, B. V., Di Chiacchio, N., and Neto, D. R. Foam during reconstitution does not affect the potency of botulinum toxin type A. Dermatol. Surg. 29: 530, 2003.
9. Carruthers, A., Kiene, K., and Carruthers, J. Botulinum A exotoxin use in clinical dermatology. J. Am. Acad. Dermatol. 34: 788, 1996.
10. Fagien, S. Botulinum toxin type A for facial aesthetic enhancement: Role in facial shaping. Plast. Reconstr. Surg. 112 (Suppl.): 6S, 2003.
11. Ahn, K. Y., Park, M. Y., Park, D. H., and Han, D. G. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast. Reconstr. Surg. 105: 778, 2000.
12. Alam, M., Dover, J. S., Klein, A. W., and Arndt, K. A. Botulinum A exotoxin for hyperfunctional facial lines: Where not to inject. Arch. Dermatol. 138: 1180, 2002.
13. Carruthers, A., and Carruthers, J. Long-term safety review of subjects treated with botulinum toxin type A for cosmetic use. In Proceedings of the 13th Congress of the European Academy of Dermatology & Venereology, Florence, Italy, November 17-21, 2004.
14. Matarasso, S. L. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol. Surg. 24: 1249, 1998.
15. Carruthers, J. D., and Carruthers, J. A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J. Dermatol. Surg. Oncol. 18: 17, 1992.
16. Sommer, B., Zschocke, I., Bergfeld, D., Sattler, G., and Augustin, M. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol. Surg. 29: 456, 2003.
17. Klein, A. W. Cosmetic therapy with botulinum toxin: Anecdotal memoirs. Dermatol. Surg. 22: 757, 1996.
18. Blitzer, A., Brin, M. F., Keen, M. S., and Aviv, J. E. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch. Otolaryngol. Head Neck Surg. 119: 1018, 1993.
19. Carruthers, A., and Carruthers, J. A. Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles. In J. Jankovic and M. Hallett (Eds.), Therapy with Botulinum Toxin. New York: Marcel Dekker, 1994. Pp. 577-595.
20. Carruthers, J. D., Lowe, N. J., Menter, M. A., et al. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast. Reconstr. Surg. 112: 1089, 2003.
21. Carruthers, A., Carruthers, J., and Said, S. Double-blind, randomized, parallel group, dose-ranging study of botulinum toxin type A (Botox, Allergan, Inc.) in the treatment of glabellar lines. Poster presented at the European Academy of Dermatology and Venereology meeting, Munich, Germany, October 10, 2001.
22. Carruthers, J. A., Lowe, N. J., Menter, M. A., et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J. Am. Acad. Dermatol. 46: 840, 2002.
23. Carruthers, A., and Carruthers, J. Botulinum toxin type A for treating glabellar lines in men: A dose ranging study. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, Calif., March 21-26, 2003.
24. Fagien, S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast. Reconstr. Surg. 103: 701, 1999.
25. Frankel, A. S., and Kamer, F. M. Chemical browlift. Arch. Otolaryngol. Head Neck Surg. 124: 321, 1998.
26. Grimes, P. E. A four-month randomized, double-masked evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. Poster presented at the 62nd Annual Meeting of the American Academy of Dermatology, Washington, D.C., February 6-11, 2004.
27. Guerrissi, J., and Sarkissian, P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann. Plast. Surg. 39: 447, 1997.
28. Guyuron, B., and Huddleston, S. W. Aesthetic indications for botulinum toxin injection. Plast. Reconstr. Surg. 93: 913, 1994.
29. Hankins, C. L., Strimling, R., and Rogers, G. S. Botulinum A toxin for glabellar wrinkles: Dose and response. Dermatol. Surg. 24: 1181, 1998.
30. Blitzer, A., Binder, W. J., Aviv, J. E., Keen, M. S., and Brin, M. F. The management of hyperfunctional facial lines with botulinum toxin: A collaborative study of 210 injection sites in 162 patients. Arch. Otolaryngol. Head Neck Surg. 123: 389, 1997.
31. Lew, H., Yun, Y. S., Lee, S. Y., and Kim, S. J. Effect of botulinum toxin A on facial wrinkle lines in Koreans. Ophthalmologica 216: 50, 2002.
32. Lowe, N. J., Maxwell, A., and Harper, H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J. Am. Acad. Dermatol. 35: 569, 1996.
33. Pribitkin, E. A., Greco, T. M., Goode, R. L., and Keane, W. M. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch. Otolaryngol. Head Neck Surg. 123: 321, 1997.
34. Saray, Y., and Gulec, T. Botulinum exotoxin-A for treatment of facial rhytides (Abstract A43). J. Cosmet. Dermatol. 1: 166, 2003.
35. 2 laser resurfacing. Dermatol. Surg. 25: 259, 1999.
36. Zimbler, M. S., Holds, J. B., Kokoska, M. S., et al. Effect of botulinum toxin pretreatment on laser resurfacing results: A prospective, randomized, blinded trial. Arch. Facial Plast. Surg. 3: 165, 2001.
37. Sommer, B., and Sattler, G. Botulinum Toxin in Aesthetic Medicine. Berlin: Blackwell Wissenschafts-Verlag, 2001.
38. Wieder, J. M., and Moy, R. L. Understanding botulinum toxin: Surgical anatomy of the frown, forehead, and periocular region. Dermatol. Surg. 24: 1172, 1998.
39. Kaminer, M. S., and Hruza, G. J. Botulinum A exotoxin injections for photoaging and hyperhidrosis. In M. S. Kaminer, J. S. Dover, and K. A. Arndt (Eds.), Atlas of Cosmetic Surgery, 1st Ed. Philadelphia: Saunders, 2002. Pp. 292-309.
40. Bulstrode, N. W., and Grobbelaar, A. O. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthetic Plast. Surg. 26: 356, 2002.
41. Carruthers, A., Carruthers, J., and Cohen, J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol. Surg. 29: 461, 2003.
42. Flynn, T. C., and Clark, R. E. Botulinum toxin type B (Myobloc) versus botulinum toxin type A (Botox) frontalis study: Rate of onset and radius of diffusion. Dermatol. Surg. 29: 519, 2003.
43. Han, K. H., Seo, K. I., Won, C. H., and Eun, H. C. Comparison of two botulinum toxin type A preparations in the treatment of hyperkinetic facial wrinkles (Abstract). Korean J. Dermatol. 41 (Suppl. 1): 4, 2003.
44. Keen, M., Blitzer, A., Aviv, J. E., et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast. Reconstr. Surg. 94: 94, 1994.
45. Le Louarn, C. Botulinum toxin A and facial lines: The variable concentration. Aesthetic Plast. Surg. 25: 73, 2001.
46. Klein, A. W., Wexler, P., Carruthers, A., and Carruthers, J. Treatment of facial furrows and rhytides. Dermatol. Clin. 15: 595, 1997.
47. Carruthers, A., and Carruthers, J. Cosmetic uses of botulinum A exotoxin. Adv. Dermatol. 12: 325, 1997.
48. Flynn, T. C., Carruthers, J. A., Carruthers, J. A., and Clark, R. E., II. Botulinum A toxin (Botox) in the lower eyelid: Dose-finding study. Dermatol. Surg. 29: 943, 2003.
49. Guerrissi, J. O. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet. Plast. Reconstr. Surg. 112 (Suppl.): 161S, 2003.
50. Lowe, N. J., Lask, G., Yamauchi, P., and Moore, D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J. Am. Acad. Dermatol. 47: 834, 2002.
51. Lowe, N. J., Yamauchi, P., Lask, G., and Moore, D. Botox-A gives adjunctive benefit to periorbital laser resurfacing (Abstract 267). Lasers Surg. Med. Suppl. 14: 73, 2002.
52. Matarasso, S. L. Comparison of botulinum toxin types A and B: A bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol. Surg. 29: 7, 2003.
53. Kane, M. A. Classification of crow's feet patterns among Caucasian women: The key to individualizing treatment. Plast. Reconstr. Surg. 112 (Suppl.): 33S, 2003.
54. Mythos Anatomy. WebMD Anatomy. Available at http:// www.mythos.com/webmd. Accessed June 9, 2004.
55. Gray's Anatomy Online. Available at http://education.yahoo.com/reference/ gray/106.htm. Accessed June 9, 2004.
56. Matarasso, S. L., and Matarasso, A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast. Reconstr. Surg. 108: 208, 2001.
57. Brandt, F. S. A prospective, placebo-controlled, randomized, parallel group study of botulinum toxin type A for the treatment of mild to moderate platysmal bands. Poster presented at the 62nd Annual Meeting of the American Academy of Dermatology, Washington, D.C., February 6-11, 2004.
58. Carruthers, J., and Carruthers, A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol. Surg. 29: 468, 2003.
59. Kane, M. A. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A. Plast. Reconstr. Surg. 103: 656, 1999.
60. Kane, M. A. Nonsurgical treatment of platysma bands with injection of botulinum toxin A revisited. Plast. Reconstr. Surg 112 (Suppl.): 125S, 2003.
61. Matarasso, A., and Matarasso, S. L. Botulinum A exotoxin for the management of platysma bands. Plast. Reconstr. Surg 112 (Suppl.): 127S, 2003.
62. Blitzer, A. Botulinum neurotoxin A for the management of lower facial lines and platysmal bands. In N. Lowe (Ed.), Textbook of Facial Rejuvenation: The Art of Minimally Invasive Combination Therapy. London: Martin Dunitz, 2002.